SCHEMBL1912103

SCHEMBL1912103

CCOc1cc(CCN(CC)CCN(C)C)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1

nearest known ligand 0.73

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ALK Q9UM73 19/20 0.73
▸ INSR P06213 13/20 0.73
▸ EGFR P00533 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20085649 0.84 ALK (1.00) ALKINSR
SCHEMBL20085724 0.83 ALK (1.00) ALKINSR
SCHEMBL12892750 0.82 ALK (0.62) ALKINSREGFR
SCHEMBL12780219 0.82 ALK (0.71) ALKINSREGFR
SCHEMBL12918397 0.81 AXL (0.56) ALKINSREGFR
SCHEMBL14981305 0.80 ALK (0.74) ALKINSREGFR
SCHEMBL20085674 0.79 ALK (1.00) ALKINSR
SCHEMBL12892751 0.77 ALK (0.75) ALKINSREGFR
SCHEMBL12892749 0.77 ALK (0.75) ALKINSREGFR
SCHEMBL18877727 0.77 ALK (0.85) ALKINSREGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1660458-B1 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS NOVARTIS AG (CH) 2012-01-25 — — EP disclosed
Send feedback